A Trial to Test the Safety and Efficacy of TEV-53408 in Treating Vitiligo
NCT06625177
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
38
Enrollment
INDUSTRY
Sponsor class
Conditions
Vitiligo
Interventions
DRUG:
TEV-53408
Sponsor
Teva Branded Pharmaceutical Products R&D LLC